Service Configures Ready-Made Solution for Randomization and Trial Supply Management
Service Configures Ready-Made Solution for Randomization and Trial Supply Management
ClinPhone (Nottingham, UK) announces its ClinPhone Compact, a new service created to meet the needs of many conventional study designs by offering a ready-made application for Interactive Voice Response and Interactive Web Response deployment.
eShowcase: ClinPhone Compact
The new service is hosted by ClinPhone and utilizes its existing infrastructure offerings of 24/7 global support, unlimited language capabilities, and an extensive toll-free network of 82 countries.
ClinPhone Compact allows pharmaceutical and biotechnology sponsors to perform central randomization, emergency code break, medication dispensation, and site and depot supplies management combined with real-time study progress reporting. Because the solution is ready-made, it minimizes the need for study-specific customization, including programming, testing, and validation. As such, this can lower sponsors' costs and accelerate timelines.
ClinPhone plc, +44 (0)115 9557555, www.clinphone.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.